• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

EphA2通过与Akt相互作用促进神经胶质瘤干细胞在体内的浸润性侵袭,并调节干细胞特性。

EphA2 promotes infiltrative invasion of glioma stem cells in vivo through cross-talk with Akt and regulates stem cell properties.

作者信息

Miao H, Gale N W, Guo H, Qian J, Petty A, Kaspar J, Murphy A J, Valenzuela D M, Yancopoulos G, Hambardzumyan D, Lathia J D, Rich J N, Lee J, Wang B

机构信息

1] Rammelkamp Center for Research, MetroHealth Medical Center, Case Western Reserve University School of Medicine, Cleveland, OH, USA [2] Department of Pharmacology and Oncology, Case Western Reserve University School of Medicine, Cleveland, OH, USA.

VelociGene Division, Regeneron Pharmaceuticals Inc., Tarrytown, NY, USA.

出版信息

Oncogene. 2015 Jan 29;34(5):558-67. doi: 10.1038/onc.2013.590. Epub 2014 Feb 3.

DOI:10.1038/onc.2013.590
PMID:24488013
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC4119862/
Abstract

Diffuse infiltrative invasion is a major cause for the dismal prognosis of glioblastoma multiforme (GBM), but the underlying mechanisms remain incompletely understood. Using human glioma stem cells (GSCs) that recapitulate the invasive propensity of primary GBM, we find that EphA2 critically regulates GBM invasion in vivo. EphA2 was expressed in all seven GSC lines examined, and overexpression of EphA2 enhanced intracranial invasion. The effects required Akt-mediated phosphorylation of EphA2 on serine 897. In vitro the Akt-EphA2 signaling axis is maintained in the absence of ephrin-A ligands and is disrupted upon ligand stimulation. To test whether ephrin-As in tumor microenvironment can regulate GSC invasion, the newly established Efna1;Efna3;Efna4 triple knockout mice (TKO) were used in an ex vivo brain slice invasion assay. We observed significantly increased GSC invasion through the brain slices of TKO mice relative to wild-type (WT) littermates. Mechanistically EphA2 knockdown suppressed stem cell properties of GSCs, causing diminished self-renewal, reduced stem marker expression and decreased tumorigenicity. In a subset of GSCs, the reduced stem cell properties were associated with lower Sox2 expression. Overexpression of EphA2 promoted stem cell properties in a kinase-independent manner and increased Sox2 expression. Disruption of Akt-EphA2 cross-talk attenuated stem cell marker expression and neurosphere formation while having minimal effects on tumorigenesis. Taken together, the results show that EphA2 endows invasiveness of GSCs in vivo in cooperation with Akt and regulates glioma stem cell properties.

摘要

弥漫性浸润性侵袭是多形性胶质母细胞瘤(GBM)预后不良的主要原因,但其潜在机制仍未完全阐明。利用能够重现原发性GBM侵袭倾向的人胶质瘤干细胞(GSCs),我们发现EphA2在体内对GBM侵袭起着关键调节作用。在所检测的7种GSC系中均表达EphA2,EphA2的过表达增强了颅内侵袭。这些效应需要Akt介导的EphA2丝氨酸897位点的磷酸化。在体外,Akt-EphA2信号轴在缺乏ephrin-A配体的情况下得以维持,而在配体刺激时被破坏。为了测试肿瘤微环境中的ephrin-As是否能调节GSC侵袭,我们将新建立的Efna1;Efna3;Efna4三基因敲除小鼠(TKO)用于离体脑片侵袭试验。我们观察到,相对于野生型(WT)同窝小鼠,GSC通过TKO小鼠脑片的侵袭显著增加。从机制上讲,EphA2的敲低抑制了GSCs的干细胞特性,导致自我更新能力下降、干细胞标志物表达减少以及致瘤性降低。在一部分GSCs中,干细胞特性的降低与较低的Sox2表达有关。EphA2的过表达以不依赖激酶的方式促进干细胞特性并增加Sox2表达。Akt-EphA2相互作用的破坏减弱了干细胞标志物的表达和神经球的形成,而对肿瘤发生的影响最小。综上所述,结果表明EphA2与Akt协同赋予GSCs体内侵袭性,并调节胶质瘤干细胞特性。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ed52/4119862/a06aa24dbf93/nihms-551118-f0006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ed52/4119862/a3e16036ec64/nihms-551118-f0001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ed52/4119862/406c6cff93a3/nihms-551118-f0002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ed52/4119862/dbd4d072f18e/nihms-551118-f0003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ed52/4119862/a96fbe6ff055/nihms-551118-f0004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ed52/4119862/971c374a7870/nihms-551118-f0005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ed52/4119862/a06aa24dbf93/nihms-551118-f0006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ed52/4119862/a3e16036ec64/nihms-551118-f0001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ed52/4119862/406c6cff93a3/nihms-551118-f0002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ed52/4119862/dbd4d072f18e/nihms-551118-f0003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ed52/4119862/a96fbe6ff055/nihms-551118-f0004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ed52/4119862/971c374a7870/nihms-551118-f0005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ed52/4119862/a06aa24dbf93/nihms-551118-f0006.jpg

相似文献

1
EphA2 promotes infiltrative invasion of glioma stem cells in vivo through cross-talk with Akt and regulates stem cell properties.EphA2通过与Akt相互作用促进神经胶质瘤干细胞在体内的浸润性侵袭,并调节干细胞特性。
Oncogene. 2015 Jan 29;34(5):558-67. doi: 10.1038/onc.2013.590. Epub 2014 Feb 3.
2
Hypoxia-induced TGFBI maintains glioma stem cells by stabilizing EphA2.缺氧诱导的 TGFBI 通过稳定 EphA2 维持神经胶质瘤干细胞。
Theranostics. 2024 Sep 9;14(15):5778-5792. doi: 10.7150/thno.95141. eCollection 2024.
3
NFAT1-Mediated Regulation of NDEL1 Promotes Growth and Invasion of Glioma Stem-like Cells.NFAT1 介导的 NDEL1 调控促进神经胶质瘤干细胞的生长和侵袭。
Cancer Res. 2019 May 15;79(10):2593-2603. doi: 10.1158/0008-5472.CAN-18-3297. Epub 2019 Apr 2.
4
Essential role of METTL3-mediated mA modification in glioma stem-like cells maintenance and radioresistance.METTL3 介导的 mA 修饰在神经胶质瘤干细胞维持和放射抵抗中的重要作用。
Oncogene. 2018 Jan 25;37(4):522-533. doi: 10.1038/onc.2017.351. Epub 2017 Oct 9.
5
CircABCC3 knockdown inhibits glioblastoma cell malignancy by regulating miR-770-5p/SOX2 axis through PI3K/AKT signaling pathway.环状 RNA ABCC3 敲低通过 PI3K/AKT 信号通路调控 miR-770-5p/SOX2 轴抑制脑胶质母细胞瘤细胞恶性表型。
Brain Res. 2021 Aug 1;1764:147465. doi: 10.1016/j.brainres.2021.147465. Epub 2021 Mar 31.
6
A novel extracellular Hsp90 mediated co-receptor function for LRP1 regulates EphA2 dependent glioblastoma cell invasion.一种新型细胞外热休克蛋白 90 介导的 LRP1 共受体功能调节 EphA2 依赖的神经胶质瘤细胞侵袭。
PLoS One. 2011 Mar 8;6(3):e17649. doi: 10.1371/journal.pone.0017649.
7
Cotargeting Ephrin Receptor Tyrosine Kinases A2 and A3 in Cancer Stem Cells Reduces Growth of Recurrent Glioblastoma.靶向癌干细胞中 Ephrin 受体酪氨酸激酶 A2 和 A3 减少复发性脑胶质瘤的生长。
Cancer Res. 2018 Sep 1;78(17):5023-5037. doi: 10.1158/0008-5472.CAN-18-0267. Epub 2018 Jun 26.
8
Growth factor independence underpins a paroxysmal, aggressive Wnt5a/EphA2 phenotype in glioblastoma stem cells, conducive to experimental combinatorial therapy.生长因子独立性是胶质母细胞瘤干细胞中突发、侵袭性的 Wnt5a/EphA2 表型的基础,有利于实验性联合治疗。
J Exp Clin Cancer Res. 2022 Apr 12;41(1):139. doi: 10.1186/s13046-022-02333-1.
9
Xihuang Pill-destabilized CD133/EGFR/Akt/mTOR cascade reduces stemness enrichment of glioblastoma via the down-regulation of SOX2.西黄丸破坏 CD133/EGFR/Akt/mTOR 级联减少通过下调 SOX2 富集神经胶质瘤干细胞。
Phytomedicine. 2023 Jun;114:154764. doi: 10.1016/j.phymed.2023.154764. Epub 2023 Mar 16.
10
Glioblastoma Stem Cell-Derived Exosomes Enhance Stemness and Tumorigenicity of Glioma Cells by Transferring Notch1 Protein.胶质母细胞瘤干细胞衍生的外泌体通过转移 Notch1 蛋白增强神经胶质瘤细胞的干性和致瘤性。
Cell Mol Neurobiol. 2020 Jul;40(5):767-784. doi: 10.1007/s10571-019-00771-8. Epub 2019 Dec 18.

引用本文的文献

1
Phenotypic variations in glioma stem cells: regulatory mechanisms and implications for therapeutic strategies.胶质瘤干细胞的表型变异:调控机制及其对治疗策略的影响
J Transl Med. 2025 Sep 2;23(1):984. doi: 10.1186/s12967-025-07034-9.
2
EphA2 and Ephrin-A1 Utilize the Same Interface for Both and Interactions That Differentially Regulate Cell Signaling and Function.EphA2和Ephrin-A1利用相同的界面进行正向和反向相互作用,这些相互作用以不同方式调节细胞信号传导和功能。
bioRxiv. 2025 Aug 2:2025.07.31.667925. doi: 10.1101/2025.07.31.667925.
3
The invasion phenotypes of glioblastoma depend on plastic and reprogrammable cell states.

本文引用的文献

1
The integrated landscape of driver genomic alterations in glioblastoma.胶质母细胞瘤中驱动基因改变的综合景观。
Nat Genet. 2013 Oct;45(10):1141-9. doi: 10.1038/ng.2734. Epub 2013 Aug 5.
2
EphA3 maintains tumorigenicity and is a therapeutic target in glioblastoma multiforme.EphA3 维持肿瘤发生能力,是多形性胶质母细胞瘤的治疗靶点。
Cancer Cell. 2013 Feb 11;23(2):238-48. doi: 10.1016/j.ccr.2013.01.007.
3
Tumor-specific activation of the C-JUN/MELK pathway regulates glioma stem cell growth in a p53-dependent manner.C-JUN/MELK 通路的肿瘤特异性激活以依赖 p53 的方式调节神经胶质瘤干细胞的生长。
胶质母细胞瘤的侵袭表型取决于可塑性和可重编程的细胞状态。
Nat Commun. 2025 Jul 19;16(1):6662. doi: 10.1038/s41467-025-61999-1.
4
Glutamine Metabolism: Molecular Regulation, Biological Functions, and Diseases.谷氨酰胺代谢:分子调控、生物学功能与疾病
MedComm (2020). 2025 Jun 25;6(7):e70120. doi: 10.1002/mco2.70120. eCollection 2025 Jul.
5
Targeting Glioblastoma Stem Cells: A40s Aptamer-NIR-Dye Conjugate for Glioblastoma Visualization and Treatment.靶向胶质母细胞瘤干细胞:用于胶质母细胞瘤可视化和治疗的A40s适配体-近红外染料偶联物
Biomolecules. 2025 May 27;15(6):768. doi: 10.3390/biom15060768.
6
Targeting Glioblastoma Stem Cells via EphA2: Structural Insights into the RNA Aptamer A40s for Precision Therapy.通过EphA2靶向胶质母细胞瘤干细胞:用于精准治疗的RNA适配体A40s的结构见解
J Chem Inf Model. 2025 Jun 9;65(11):5635-5648. doi: 10.1021/acs.jcim.5c00295. Epub 2025 May 23.
7
Personalized mRNA vaccines in glioblastoma therapy: from rational design to clinical trials.个性化信使 RNA 疫苗在胶质母细胞瘤治疗中的应用:从合理设计到临床试验。
J Nanobiotechnology. 2024 Oct 4;22(1):601. doi: 10.1186/s12951-024-02882-x.
8
Unraveling the role of EPHA2 in regulating migration and immunomodulation processes in cervical cancer: exploring the synergic effect of 17β-estradiol on cancer progression.解析 EphA2 在调控宫颈癌迁移和免疫调节过程中的作用:探索 17β-雌二醇对癌症进展的协同作用。
Med Oncol. 2024 Oct 1;41(11):255. doi: 10.1007/s12032-024-02508-0.
9
Hypoxia-induced TGFBI maintains glioma stem cells by stabilizing EphA2.缺氧诱导的 TGFBI 通过稳定 EphA2 维持神经胶质瘤干细胞。
Theranostics. 2024 Sep 9;14(15):5778-5792. doi: 10.7150/thno.95141. eCollection 2024.
10
Unveiling the therapeutic promise of EphA2 in glioblastoma: a comprehensive review.揭示EphA2在胶质母细胞瘤中的治疗前景:一项全面综述
Discov Oncol. 2024 Sep 27;15(1):501. doi: 10.1007/s12672-024-01380-8.
Stem Cells. 2013 May;31(5):870-81. doi: 10.1002/stem.1322.
4
The EphA2 receptor drives self-renewal and tumorigenicity in stem-like tumor-propagating cells from human glioblastomas.EphA2 受体驱动源自人胶质母细胞瘤的干细胞样肿瘤起始细胞的自我更新和致瘤性。
Cancer Cell. 2012 Dec 11;22(6):765-80. doi: 10.1016/j.ccr.2012.11.005.
5
A small molecule agonist of EphA2 receptor tyrosine kinase inhibits tumor cell migration in vitro and prostate cancer metastasis in vivo.EphA2 受体酪氨酸激酶的小分子激动剂抑制体外肿瘤细胞迁移和体内前列腺癌转移。
PLoS One. 2012;7(8):e42120. doi: 10.1371/journal.pone.0042120. Epub 2012 Aug 15.
6
Transforming fusions of FGFR and TACC genes in human glioblastoma.人类胶质母细胞瘤中 FGFR 和 TACC 基因的融合转化。
Science. 2012 Sep 7;337(6099):1231-5. doi: 10.1126/science.1220834. Epub 2012 Jul 26.
7
EphrinA1 is released in three forms from cancer cells by matrix metalloproteases.EphrinA1 可通过基质金属蛋白酶从癌细胞中以三种形式释放。
Mol Cell Biol. 2012 Aug;32(16):3253-64. doi: 10.1128/MCB.06791-11. Epub 2012 Jun 11.
8
Emerging insights into the molecular and cellular basis of glioblastoma.胶质母细胞瘤的分子和细胞基础的新见解。
Genes Dev. 2012 Apr 15;26(8):756-84. doi: 10.1101/gad.187922.112.
9
SOX after SOX: SOXession regulates neurogenesis.SOX 之后的 SOX:SOX 因子调控神经发生。
Genes Dev. 2011 Dec 1;25(23):2423-8. doi: 10.1101/gad.181487.111.
10
EphA receptor signaling--complexity and emerging themes.EphA 受体信号转导——复杂性与新兴主题。
Semin Cell Dev Biol. 2012 Feb;23(1):16-25. doi: 10.1016/j.semcdb.2011.10.013. Epub 2011 Oct 21.